COLLABORATIVE CARE DIAGNOSTICS, LLC

COLLABORATIVE CARE DIAGNOSTICS, LLC specializes in the design, development, and lifecycle management of electromedical and electrophysiological diagnostic apparatuses, with a focus on clinical-grade devices that support patient monitoring and therapeutic intervention. Their technical expertise lies in the integration of biomedical sensors, signal processing systems, and FDA-regulated software controls to produce compliant medical devices. The company demonstrates proficiency in regulatory alignment for Class II medical equipment, including adherence to IEC 60601 standards and quality management practices aligned with ISO 13485, though formal certifications are not currently listed. Their approach emphasizes reliability in low-power, high-precision instrumentation used in ambulatory and institutional care environments. The contractor has delivered solutions to the Department of Health and Human Services, primarily supporting equipment closeout and operational deobsolescence initiatives for federal healthcare programs. This suggests experience in managing the transition of legacy medical systems, ensuring continuity of care during device retirement or upgrade cycles, and maintaining compliance with federal procurement and asset disposition protocols. Their primary industry focus is in the manufacturing of electromedical apparatuses, a niche requiring stringent engineering controls, biocompatible materials, and electromagnetic compatibility design. The company positions itself within the federal medical device supply chain, serving public health infrastructure with specialized hardware that bridges clinical needs and regulatory requirements. As a small business structured as a 2L entity, COLLABORATIVE CARE DIAGNOSTICS, LLC operates from Saint Paul, Minnesota, with a focused presence in the federal healthcare technology market. While currently unaffiliated with formal government certifications such as 8(a), HUBZone, or WOSB, their technical work demonstrates alignment with federal procurement priorities in medical device sustainment and innovation.